|
FAM185A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62547753035369E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.4432899320127E-14 |
| Normal-vs-Stage2 |
4.71719999994846E-06 |
| Normal-vs-Stage3 |
1.46360701336334E-12 |
| Normal-vs-Stage4 |
1.46540002354811E-09 |
| Stage1-vs-Stage2 |
1.764430E-01 |
| Stage1-vs-Stage3 |
1.650580E-01 |
| Stage1-vs-Stage4 |
2.110000E-01 |
| Stage2-vs-Stage3 |
4.627900E-02 |
| Stage2-vs-Stage4 |
6.984200E-02 |
| Stage3-vs-Stage4 |
8.688600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.593400E-04 |
| Normal-vs-Asian |
1.33448807559944E-12 |
| Caucasian-vs-AfricanAmerican |
3.892300E-02 |
| Caucasian-vs-Asian |
3.179400E-01 |
| AfricanAmerican-vs-Asian |
9.777400E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.44229969581511E-10 |
| Normal-vs-Female |
1.62525548574877E-12 |
| Male-vs-Female |
1.826380E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63935531816151E-12 |
| Normal-vs-Age(41-60Yrs) |
2.4535928844216E-14 |
| Normal-vs-Age(61-80Yrs) |
1.35590000005514E-07 |
| Normal-vs-Age(81-100Yrs) |
3.813700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.392800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.127600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.705200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.821050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.076800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.015000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.297000E-03 |
| Classical-VS-Follicular |
1.441280E-04 |
| Classical-VS-Other |
7.086600E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
5.62310000007393E-07 |
| Tall-VS-Other |
8.255600E-02 |
| Tall-VS-Normal |
1.96065386148803E-13 |
| Follicular-VS-Other |
3.441400E-01 |
| Follicular-VS-Normal |
8.834500E-04 |
| Other-VS-Normal |
5.998000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.99760216648792E-14 |
| Normal-vs-N1 |
1.62549973481418E-10 |
| N0-vs-N1 |
1.360200E-01 |
|
|
